Mayer M, Ochmann O, Doenicke A, Angster R, Suttmann H
Institut für Anaesthesiologie, Ludwig-Maximilians-Universität, Bereich Innenstadt, München.
Anaesthesist. 1990 Dec;39(12):609-16.
Propofol (Diprivan), a modern intravenous hypnotic, produces a reduction in both cardiac index (CI) and mean arterial pressure (MAP). Ketamine (Ketanest), a potent analgesic, in contrast, causes an increase in MAP and CI. The aim of the present study was to investigate whether the combination of propofol and ketamine can give better hemodynamic stability during the induction and maintenance of general anesthesia than propofol used with fentanyl, whose cardiodepressant actions may cumulate. METHODS. For induction of general anesthesia 10 patients (ASA I and II) each received 3-5 boluses of propofol (0.5 mg.kg-1 during 35 s until predetermined level of anesthesia was reached (stage D2/E0 according to [20]) followed by a continuous propofol infusion (0.120 mg.kg-1.min). Fentanyl 0.1 mg was administered to each patient in group A for induction of anesthesia and again if evident pain was present. In group B ketamine was given following a pharmacokinetic model based on computer-simulated calculation. After an initial bolus of 38 mg injected within 2 min further doses of 42 mg, 35 mg, 32 mg and 28 mg ketamine were administered over 30 min at a time. Signs of evident pain were treated by means of supplementary doses of 0.5 mg.kg-1. RESULTS. In both groups a moderate drop of MAP was observed after the induction of general anesthesia. Two patients in each group showed a distinct decrease in MAP (-32%). The heart rate dropped slightly (-9%) in group A, but did not change in group B. Following intubation the MAP rose by less in group A (+8%) than in group B (+21%). After the beginning of the operation the group treated with propofol/fentanyl showed major hemodynamic changes; in particular, bradycardia with less than 40 bpm was observed in more patients than in the propofol/ketamine group. Postoperatively, fewer patients in group B required rescue doses of analgesics (1 of 10) than these in group A (7 of 10), though vigilance was better in group B. DISCUSSION. The dose of ketamine administered during the induction of general anesthesia may have been not high enough to neutralize the cardiodepressant effect of propofol. But during the maintenance of anesthesia there was in fact better hemodynamic stability in group B than in group A as a result of the neutralization of opposing actions. Fentanyl even intensified the fall in MAP after propofol. Patients in group B showed better vigilance as well as better pain relief postoperatively. The population of the fentanyl group was obviously more deeply sedated and analgesia was still inadequate. In our study general intravenous anesthesia with propofol and ketamine offered the advantages of better analgesia, a higher state of vigilance and the absence of respiratory depression during the postoperative phase compared with the combination of propofol and fentanyl.
丙泊酚(得普利麻)是一种现代静脉催眠药,可使心脏指数(CI)和平均动脉压(MAP)降低。相比之下,强效镇痛药氯胺酮(凯他敏)可使MAP和CI升高。本研究的目的是调查与丙泊酚联合芬太尼相比,丙泊酚与氯胺酮联合使用在全身麻醉诱导和维持期间是否能提供更好的血流动力学稳定性,芬太尼的心脏抑制作用可能会累积。方法。为诱导全身麻醉,10例患者(美国麻醉医师协会I级和II级)每人接受3 - 5次丙泊酚推注(35秒内0.5mg·kg-1,直至达到预定麻醉水平(根据[20]为D2/E0期),随后持续输注丙泊酚(0.120mg·kg-1·min)。A组每名患者给予0.1mg芬太尼用于诱导麻醉,若出现明显疼痛则再次给药。B组根据基于计算机模拟计算的药代动力学模型给予氯胺酮。在2分钟内首次推注38mg后,在30分钟内每次再给予42mg、35mg、32mg和28mg氯胺酮。明显疼痛的体征通过补充剂量0.5mg·kg-1进行处理。结果。两组在全身麻醉诱导后均观察到MAP适度下降。每组有两名患者MAP明显下降(-32%)。A组心率略有下降(-9%),而B组心率未变化。插管后,A组MAP升高幅度(+8%)小于B组(+21%)。手术开始后,丙泊酚/芬太尼治疗组出现较大的血流动力学变化;特别是,与丙泊酚/氯胺酮组相比,更多患者出现心率低于40次/分的心动过缓。术后,B组需要抢救剂量镇痛药的患者(10例中的1例)少于A组(10例中的7例),尽管B组的警觉性更好。讨论。全身麻醉诱导期间给予的氯胺酮剂量可能不足以抵消丙泊酚的心脏抑制作用。但在麻醉维持期间,由于相反作用的中和,B组实际上比A组具有更好的血流动力学稳定性。芬太尼甚至加剧了丙泊酚后MAP的下降。B组患者术后警觉性更好,疼痛缓解也更好。芬太尼组的患者明显镇静更深,镇痛仍不足。在我们的研究中,与丙泊酚和芬太尼联合使用相比,丙泊酚和氯胺酮的全身静脉麻醉具有更好的镇痛效果、更高的警觉状态以及术后无呼吸抑制的优点。